Lilly Is Selling Zepbound Vials at 50% Discount to Shots

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg News Health Care Reporter Madison Muller discusses Eli Lilly selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots. Silvio Tavares, CEO of VantageScore, provides the firm's credit data gauge of consumers. Bloomberg Businessweek Senior Editor Bret Begun shares stories from the Businessweek Magazine package on sports gambling. Ian Rogers, Chief Experience Officer at Ledger, talks about providing digital asset security for consumers and enterprises. And we Drive to the Close with Emily Roland, Co-Chief Investment Strategist at John Hancock Investment Management.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

See omnystudio.com/listener for privacy information.